Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_assertion type Assertion NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_head.
- NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_provenance.
- NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_assertion evidence source_evidence_literature NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_provenance.
- NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_assertion SIO_000772 20530282 NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_provenance.
- NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_assertion wasDerivedFrom gad-20150221 NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_provenance.
- NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_assertion wasGeneratedBy ECO_0000203 NP177865.RAxzjvEQbV-Y-c9f5yTgtXch3m05L1MAROMsxPVEn2250130_provenance.